BGX Sofix Ucits Etf

    RNS Number : 5606L
  Rowan Dartington & Co. Limited
  13 January 2009
   

                                 FORM 8.1                        
    DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES
    FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
    (Rules 8.1(a) and (b)(i) of the Takeover Code)


    1.    KEY INFORMATION

 Name of person dealing (Note 1)                    Rowan Dartington & Co. Ltd
 Company dealt in                                   Bioganix Plc
 Class of relevant security to which the dealings   Ordinary Shares
 being disclosed relate (Note 2)
 Date of dealing                                    12/01/2009


    2.    INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

    (a)    Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

                                                    Long            Short

                                              Number       (%)  Number    (%)

 (1) Relevant securities                      267,432           0

 (2) Derivatives (other than options)         0                 0

 (3) Options and agreements to purchase/sell  0                 0

 Total                                        267,432           0

    

(b)    Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 Class of relevant security:                      Long             Short

                                            Number       (%)  Number       (%)

 (1) Relevant securities                    0                 0

 (2) Derivatives (other than options)       0                 0

 (3) Options and agreements to              0                 0
 purchase/sell

 Total                                      0                 0


    (c)    Rights to subscribe (Note 3)

 Class of relevant security:  Details




    3.    DEALINGS (Note 4)

    (a)    Purchases and sales

 Purchase/sale  Number of securities  Price per unit (Note 5)

 Sale           10,000                0.015



    (b)    Derivatives transactions (other than options)

 Product name,   Long/short (Note 6)  Number of securities  Price per unit (Note 5)
 e.g. CFD                             (Note 7)





    (c)    Options transactions in respect of existing securities
    (i)    Writing, selling, purchasing or varying

 Product name,     Writing, selling,     Number of securities  Exercise  Type, e.g. American,  Expiry   Option money
 e.g. call option  purchasing, varying   to which the option   price     European etc.         date     paid/received per
                   etc.                  relates (Note 7)                                               unit (Note 5)



    (ii)    Exercising

 Product name, e.g. call option  Number of securities  Exercise price per unit (Note 5)



    (d)    Other dealings (including new securities) (Note 4)

 Nature of transaction (Note 8)  Details  Price per unit (if applicable) (Note
                                          5) 





    4.    OTHER INFORMATION

    Agreements, arrangements or understandings relating to options or derivatives


 Full details of any agreement, arrangement or understanding between the
 person disclosing and any other person relating to the voting rights of any
 relevant securities under any option referred to on this form or relating to
 the voting rights or future acquisition or disposal of any relevant
 securities to which any derivative referred to on this form is referenced. If
 none, this should be stated.  
 None





    Is a Supplemental Form 8 attached? (Note 9)                YES/NO


 Date of disclosure                                         13/01/2009
 Contact name                                               Christopher Keith
 Telephone number                                           01179330049
 Name of offeree/offeror with which associated              Bioganix Plc
 Specify category and nature of associate status (Note 10)


    Notes

    The Notes on Form 8.1 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk































This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
DCCBJMITMMMBBLL

Sofix Ucits Etf (LSE:BGX)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024

Sofix Ucits Etf (LSE:BGX)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024